We are live on ! Find out more
JIC

Joel Isaacson & Co Portfolio holdings

AUM $3.02B
1-Year Est. Return 21.81%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+21.81%
3 Year Est. Return
+61.27%
5 Year Est. Return
+65.83%
10 Year Est. Return
+229.48%
AUM
$298M
AUM Growth
+$22.6M
Cap. Flow
+$19M
Cap. Flow %
6.38%
Top 10 Hldgs %
62.44%
Holding
613
New
99
Increased
85
Reduced
54
Closed
20

Top Buys

Rank Stock Value
1
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$5.6M
2
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$1.24M
3
VO icon
Vanguard Mid-Cap ETF
VO
+$1.06M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$865K
5
ETO
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
+$734K

Top Sells

Rank Stock Value
1
VSI
Vitamin Shoppe Inc.
VSI
+$676K
2
DWX icon
State Street SPDR S&P International Dividend ETF
DWX
+$524K
3
GAM
General American Investors Company
GAM
+$251K
4
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$214K
5
BEAM
BEAM INC COM STK (DE)
BEAM
+$187K

Sector Composition

Rank Sector Weight
1 Healthcare 6.58%
2 Technology 4.63%
3 Financials 4.42%
4 Communication Services 4.12%
5 Consumer Staples 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FDX icon
276
FedEx
FDX
$73.5B
$53K 0.02%
400
– –
LYB icon
277
LyondellBasell Industries
LYB
$18.9B
$53K 0.02%
+600
New +$50.5K
CEM
278
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
$53K 0.02%
400
– –
AXA
279
DELISTED
AXA ADS (1 ORD SHS)
AXA
$53K 0.02%
+2,051
New +$53K
SABA
280
Saba Capital Income & Opportunities Fund II
SABA
$220M
$52K 0.02%
3,236
– –
PTLA
281
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$52K 0.02%
2,000
– –
VRNG
282
DELISTED
VRINGO, INC COM STK NEW (DE)
VRNG
$52K 0.02%
1,500
– –
AA icon
283
Alcoa
AA
$11.6B
$51K 0.02%
1,665
– –
AMP icon
284
Ameriprise Financial
AMP
$47.6B
$51K 0.02%
460
– –
KBE icon
285
State Street SPDR S&P Bank ETF
KBE
$1.63B
$51K 0.02%
1,500
– –
IWN icon
286
iShares Russell 2000 Value ETF
IWN
$14.4B
$50K 0.02%
500
– –
MOS icon
287
The Mosaic Company
MOS
$7.1B
$50K 0.02%
1,000
– –
ALL icon
288
Allstate
ALL
$67.3B
$49K 0.02%
868
+1
+0.1% +$54
SLM icon
289
SLM Corp
SLM
$4.78B
$49K 0.02%
5,596
– –
TMP icon
290
Tompkins Financial
TMP
$1.43B
$49K 0.02%
1,000
– –
TTE icon
291
TotalEnergies
TTE
$187B
$49K 0.02%
750
– –
VTRS icon
292
Viatris
VTRS
$20.5B
$49K 0.02%
1,000
– –
SMM
293
DELISTED
Salient Midstream & MLP Fund
SMM
$49K 0.02%
2,000
– –
NKE icon
294
Nike
NKE
$62.5B
$48K 0.02%
1,288
-1,220
-49% -$46.1K
OUTR
295
DELISTED
OUTERWALL INC
OUTR
$48K 0.02%
660
– –
CAT icon
296
Caterpillar
CAT
$402B
$47K 0.02%
471
– –
EWZ icon
297
iShares MSCI Brazil ETF
EWZ
$9.08B
$47K 0.02%
1,034
– –
TD icon
298
Toronto Dominion Bank
TD
$198B
$47K 0.02%
1,000
– –
HAIN icon
299
Hain Celestial
HAIN
$46M
$46K 0.02%
1,000
– –
KKR icon
300
KKR & Co
KKR
$91.3B
$46K 0.02%
2,000
– –
10 11
12
13 14

Similar funds

CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
Members Trust
Members Trust Tampa, Florida $3.01B AUM 10.24% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return
CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

Joel Isaacson & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Joel Isaacson & Co held 613 positions worth $298M, up 8.2% from $275M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Joel Isaacson & Co deployed $19M of net new capital in Q1 2014, opening 99 new positions and adding to 85 existing holdings. Its largest new stake was Invesco Biotechnology & Genome ETF: 6,890 shares worth $287K.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 6.7% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P International Dividend ETF, an estimated $524K trimmed.

  • Joel Isaacson & Co's largest Q1 2014 buy was Invesco Biotechnology & Genome ETF: 6,890 shares worth $287K.
  • Joel Isaacson & Co added most to State Street SPDR S&P Dividend ETF in Q1 2014, an estimated $5.6M increase.
  • Joel Isaacson & Co's biggest Q1 2014 reduction was State Street SPDR S&P International Dividend ETF, cutting an estimated $524K.
  • Joel Isaacson & Co fully exited Vitamin Shoppe Inc. in Q1 2014, selling an estimated $676K.
  • Joel Isaacson & Co's ten largest holdings make up 62% of its $298M portfolio in Q1 2014.
  • Joel Isaacson & Co opened 99 new positions and closed 20 in Q1 2014.
  • Joel Isaacson & Co's portfolio value rose 8.2% quarter-over-quarter to $298M.

Based on Joel Isaacson & Co's 13F filing for Q1 2014, filed 11 Apr 2014.